This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: Regeneron Pharmaceuticals, Inc.. Active years: 2020-2022.
Company Filing History:
Years Active: 2020-2022
Title: Innovations by Catherine Stehman-Breen
Introduction
Catherine Stehman-Breen is a notable inventor based in York, ME (US). She has made significant contributions to the field of pharmaceuticals, particularly in pain management and addiction prevention. With a total of 2 patents, her work focuses on innovative methods to treat lower back pain and avert opioid addiction.
Latest Patents
Catherine's latest patents include a method of treating lower back pain. This method involves administering a pharmaceutical composition that contains a therapeutically effective amount of an antibody that specifically binds to nerve growth factor (NGF) or an antigen-binding fragment thereof. Additionally, she has developed a method for averting opioid addiction in patients suffering from moderate to severe low back pain. This method includes diagnosing the patient, administering the same pharmaceutical composition, and avoiding the use of opioids, thereby relieving pain and preventing addiction.
Career Highlights
Catherine Stehman-Breen is currently associated with Regeneron Pharmaceuticals, Inc., where she continues to innovate in the pharmaceutical sector. Her work has garnered attention for its potential to change the landscape of pain management and addiction treatment.
Collaborations
Catherine collaborates with various professionals in her field, including her coworker John Davis. Their combined expertise contributes to the advancement of their projects and the development of new therapeutic methods.
Conclusion
Catherine Stehman-Breen's contributions to the field of pharmaceuticals are noteworthy, particularly in the areas of pain management and addiction prevention. Her innovative patents reflect her commitment to improving patient care and addressing critical health issues.